|
|
|
|
LEADER |
00000cam a22000004a 4500 |
001 |
7537022 |
003 |
ICU |
005 |
20090730145700.0 |
008 |
080528s2009 caua be 001 0 eng |
010 |
|
|
|a 2008022786
|
020 |
|
|
|a 9781412950848 (cloth : alk. paper)
|
020 |
|
|
|a 1412950848 (cloth : alk. paper)
|
035 |
|
|
|a 2008022786
|
035 |
|
|
|a (OCoLC)185031308
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d BTCTA
|d BAKER
|d YDXCP
|d NLM
|d NOR
|d C#P
|d UtOrBLW
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC563.4
|b .E53 2009
|
060 |
1 |
0 |
|a WM 13
|b E5825 2009
|
082 |
0 |
0 |
|a 362.2903
|2 22
|
245 |
0 |
0 |
|a Encyclopedia of substance abuse prevention, treatment, & recovery /
|c Gary L. Fisher, Nancy A. Roget, editors.
|
246 |
3 |
|
|a Encyclopedia of substance abuse prevention, treatment, and recovery
|
260 |
|
|
|a Los Angeles :
|b Sage,
|c c2009.
|
300 |
|
|
|a 2 v. (xxxiii, 1092 p.) :
|b ill. ;
|c 29 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
500 |
|
|
|a "A SAGE reference publication."
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g v. 1 --
|t List of entries --
|t Reader's guide --
|t About the editors --
|t Contributors --
|t Introduction --
|t Entries --
|g v. 2 --
|t List of entries --
|t Reader's guide --
|t Entries --
|t Appendix : Entries related to specific drugs --
|t Index.
|
505 |
0 |
0 |
|t Abstinence --
|t Abstinence violation effect --
|t Acamprosate --
|t Acceptance and commitment therapy --
|t Access to recovery --
|t Addiction, models of --
|t Addiction severity index --
|t Addiction technology transfer centers --
|t Adolescents, substance abuse and treatment --
|t Adult children of alcoholics --
|t African Americans, issues in prevention and treatment --
|t Aftercare --
|t Al-Anon --
|t Alateen --
|t Alcohol --
|t Alcoholic personality --
|t Alcoholics Anonymous --
|t Alcohol-induced disorders --
|t Alcoholism --
|t Alcohol marketing --
|t Alcohol-related birth defects --
|t Alcohol testing --
|t Alcohol Use Disorders Identification Test --
|t Alternative activities --
|t American Society of Addiction Medicine --
|t Amotivational syndrome --
|t Amphetamines --
|t Amyl nitrite --
|t Anabolic steroids --
|t Anorexia nervosa --
|t Antabuse (disulfiram) --
|t Antianxiety agents --
|t Antidepressant drugs --
|t Antipsychotic drugs --
|t Antiseizure drugs --
|t Antisocial personality disorder --
|t Anxiety disorders --
|t Anxiolytic drugs --
|t Asian Americans/Pacific Islanders, issues in prevention and treatment --
|t Assessment --
|t Assessment instruments --
|t Athletes and drug use --
|t Attention deficit hyperactivity disorder --
|t Aversive conditioning --
|t Aversive therapy --
|
505 |
0 |
0 |
|t Barbiturates --
|t Behavioral couples therapy --
|t Behavior risk factor surveillance system --
|t Behavioral therapy --
|t Benzodiazephines --
|t Biculturalism --
|t Big book, the --
|t Bill W. --
|t Binge drinking --
|t Biopsychosocial model of addiction --
|t Blood alcohol concentration --
|t Borderline personality disorder --
|t Brain chemistry and addiction --
|t Brief interventions --
|t Brief strategic family therapy --
|t Bulimia nervosa --
|t Buprenorphine --
|t Business improvement practices --
|t Caffeine --
|t CAGE screening instrument --
|t Cannabinols --
|t Cannabis youth treatment study --
|t CENAPS model --
|t Center for Substance Abuse Prevention --
|t Center for Substance Abuse Treatment --
|t Centers for the Application of Prevention Technologies --
|t Central nervous system depressants --
|t Central nervous system stimulants --
|t Certification and licensing --
|t Chemical dependency --
|t Children of alcoholics --
|t Chronicity --
|t Client engagement --
|t Client/treatment matching --
|t Clinical supervision of addiction counselors --
|t Club drugs --
|t Coalcoholic --
|t Cocaine and crack --
|t Cocaine Anonymous --
|t Codependency --
|t Coercion and treatment --
|t Cognitive behavioral therapy --
|t Cognitive-social learning model --
|t College on Problems of Drug Dependence --
|t College students, alcohol use and abuse --
|t College students, drug use and abuse --
|t COMBINE study --
|
505 |
0 |
0 |
|t Community-based processes --
|t Community reinforcement and family training --
|t Community reinforcement approach --
|t Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91-513) --
|t Confidentiality --
|t Contingency management --
|t Continuum of care --
|t Co-occurring disorders --
|t Counseling approaches --
|t Court-mandated treatment --
|t Covert sensitization --
|t Crack --
|t Craving --
|t Crime and substance abuse --
|t Criminal justice populations --
|t Cross-addictions --
|t Cultural aspects --
|t Decriminalization --
|t Demand reduction --
|t Denial --
|t Depression --
|t Detoxification --
|t Diagnosis --
|t Diagnostic and Statistical Manual of Mental Disorders --
|t Disabilities, issues in prevention and treatment --
|t Discrimination, addicted and recovering individuals --
|t Disease concept --
|t Double trouble --
|t Driving under the influence --
|t Driving while intoxicated --
|t Drug abuse --
|t Drug abuse resistance education --
|t Drug abuse screening test --
|t Drug abuse treatment outcome studies --
|t Drug abuse warning network --
|t Drug addiction --
|t Drug courts --
|t Drug-crime cycle --
|t Drug-free Schools and Communities Act --
|t Drug laws, history of --
|
505 |
0 |
0 |
|t Drugs, classification of --
|t Drug testing --
|t Drug use, history of --
|t Dry drunk syndrome --
|t Dual relationships --
|t Eating disorders --
|t Economic costs of alcohol and drug abuse --
|t Ecstasy --
|t Elderly populations, treatment issues --
|t Electronic health records --
|t Empirically based prevention --
|t Empirically based treatment --
|t Employee Assistance Program --
|t Enabling --
|t Environmental approaches --
|t Ethical standards for addiction professionals --
|t Ethics --
|t Evidence-based prevention --
|t Evidence-based prevention and treatment, dissemination and adoption of --
|t Evidence-based treatment --
|t Expectancies --
|t Experimental substance use --
|t Family behavior therapy --
|t Family counseling --
|t Family therapy --
|t Fentanyl --
|t Fetal alcohol syndrome --
|t Fetal effects of alcohol and other drugs --
|t Fidelity of prevention programs --
|
505 |
0 |
0 |
|t Gamblers Anonymous --
|t Gambling, pathological --
|t Gambling, problem --
|t Gateway drugs theory --
|t Gay, lesbian, bisexual, and transgender issues --
|t Gender issues --
|t Genetic aspects of addiction --
|t Grief, loss, and substance abuse --
|t Group therapy and counseling --
|t Hallucinogens --
|t Harm reduction, public health --
|t Harm reduction psychotherapy --
|t Hashish --
|t Health care system and substance abuse --
|t Health Insurance Portability and Accountability Act --
|t Hepatitis C --
|t Heroin --
|t High-risk behaviors --
|t High-risk situations --
|t Hispanics/Latinos, issues in prevention and treatment --
|t HIV/AIDS --
|t Homeless, substance abuse and treatment --
|t Issues in prevention ; racial and ethnic minorities --
|t Issues in treatment --
|t Ice --
|t Illicit and illegal drugs --
|t Impaired professionals --
|t Indian health services --
|t Information dissemination --
|t Informed consent --
|t Inhalants --
|t Injection drug use --
|t Inpatient treatment --
|t Institute of Medicine Classification System --
|t International Coalition for Addiction Studies Education --
|t Internet addiction --
|t Intervention --
|t Intravenous drug use --
|t Inventory of drinking situations --
|
505 |
0 |
0 |
|t Jellinek, E.M. --
|t Johnson model intervention ---
|t Join Together --
|t Legal Action Center --
|t Legalization of drugs --
|t Levo-alpha acetyl methadol --
|t Marijuana --
|t Maternal drug use --
|t Matrix model --
|t Media campaigns --
|t Medical consequences --
|t Medical use of marijuana --
|t Mentoring --
|t Methadone --
|t Methadone maintenance treatment --
|t Methamphetamine --
|t Methods of drug administration --
|t Michigan Alcohol Screening Test --
|t Minnesota model --
|t Moderation approaches to alcohol problems --
|t Moderation in use --
|t Moderation management --
|t Monitoring the future --
|t Moral model --
|t Morphine --
|t Motivational enhancement therapy --
|t Motivational interviewing --
|t Multiculturalism --
|t Multidimensional family therapy --
|
505 |
0 |
0 |
|t NAADAC, the Association for Addiction Professionals --
|t Naloxone --
|t Naltrexone --
|t Narcotics Anonymous --
|t National Clearinghouse for Alcohol and Drug Information --
|t National Council on Alcoholism and Drug Dependence --
|t National Council on Problem Gambling --
|t National Drug Control Strategy --
|t National Epidemiologic Survey on Alcohol and Related Conditions --
|t National Gambling Impact Study Commission --
|t National Institute of Mental Health --
|t National Institute on Alcohol Abuse and Alcoholism --
|t National Institute on Drug Abuse --
|t National Institute on Drug Abuse Clinical Trials Network --
|t National media campaign --
|t National outcome measures --
|t National Registry of Evidence-based Programs and Practices --
|t National Survey on Drug Use and Health --
|t National Treatment Improvement Evaluation Study --
|t Native Americans, issues in prevention and treatment --
|t Natural recovery --
|t Needle exchange programs --
|t Network for the improvement of addiction treatment --
|t Neurobiology of addiction --
|t Neurocognitive effects of alcohol and other drugs --
|t Neurotransmitters --
|t Nicotine --
|t Nicotine replacement therapy --
|
505 |
0 |
0 |
|t Office of National Drug Control Policy --
|t Opiates --
|t Opioids --
|t Other addictions --
|t Outpatient treatment --
|t Over-the-counter drugs --
|t OxyContin --
|t Pain management --
|t Patient placement criteria --
|t Peer recovery support services --
|t Pharmacological approaches to treatment --
|t Physiological aspects of drug use --
|t Post-traumatic stress disorder --
|t Prescription drugs --
|t Prevention education --
|t Prevention evaluation --
|t Prevention populations --
|t Prevention programs --
|t Prevention strategies --
|t Problem identification and referral --
|t Problem oriented screening instrument for teenagers --
|t Project MATCH --
|t Psychological models of addiction --
|t Psychosocial history --
|t Public policy, alcohol --
|t Public policy, drugs --
|t Public policy, prevention --
|t Public policy, treatment --
|t Pulse check --
|t Qualified services organization agreements --
|t Racial and ethnic minorities, issues in alcohol and other drug use --
|t Racial and ethnic minorities, issues in prevention --
|t Rapid opioid detoxification --
|t Rational recovery --
|t Recovery --
|t Recovery community organizations --
|t Recovery community services program --
|t Recovery schools --
|t Recovery support services --
|t Refusal skills --
|t Relapse --
|t Relapse prevention --
|t Research issues in prevention --
|t Research issues in treatment --
|t Residential treatment --
|t Resistance in treatment --
|t Reverse tolerance --
|t Risk and protective factor theory --
|t Risk factors for addiction --
|t Routes of administration of drugs --
|
505 |
0 |
0 |
|t School-based prevention programs --
|t School drug policies --
|t Scope of practice --
|t Screening --
|t Screening instruments --
|t Secular organizations for sobriety/Save Our Selves --
|t Sedative-hypnotics --
|t Self-change --
|t Self-help groups --
|t Self-report inventories --
|t Sex addiction --
|t Sexually transmitted diseases --
|t Shopping addiction --
|t Single state authorities --
|t Sobriety --
|t Social drinking --
|t Social learning model of addictive behaviors --
|t Social norms marketing --
|t Social skills training --
|t Sociocultural models of addiction --
|t Solution-focused therapy --
|t Special populations --
|t Spiritual issues --
|t Spontaneous remission --
|t Stages of change model --
|t State provider associations --
|t STD --
|t Steroids --
|t Stigma --
|t Student assistance program --
|t Substance abuse --
|t Substance abuse and mental health services administration --
|t Substance abuse subtle screening inventory-3 --
|t Substance dependence --
|t Substance-induced disorders --
|t Substance-induced withdrawal delirium --
|t Substance use disorders --
|t Substitute addictions --
|t Suicide --
|t Supply reduction --
|t Support groups --
|t Synanon --
|t Synar amendment --
|
505 |
0 |
0 |
|t Therapeutic communities --
|t Timeline followback --
|t Tobacco --
|t Tobacco cessation programs and treatments --
|t Tobacco marketing and countermarketing --
|t Tobacco master settlement agreement --
|t Tolerance --
|t Treatment, history of --
|t Treatment, nontraditional approaches --
|t Treatment access and retention --
|t Treatment approaches and strategies --
|t Treatment effectiveness --
|t Treatment facilities --
|t Treatment in jails and prisons --
|t Treatment of alcohol and drug use disorders --
|t Treatment plans and treatment planning --
|t Treatment programs for alcohol or drug abuse --
|t Treatment settings --
|t Tuberculosis --
|t Twelve-step facilitation --
|t Twelve-step recovery programs --
|t Twelve steps --
|t Underage drinking --
|t Urine toxicology testing --
|t Veterans, substance abuse and treatment --
|t Violence, intimate partner and substance abuse treatment --
|t Violence prevention --
|t War on drugs --
|t Welfare reform and substance abuse --
|t Willpower --
|t Withdrawal --
|t Women for sobriety --
|t Womens' issues in prevention and treatment --
|t Workplace drug policies --
|t Workplace drug use --
|t Workplace prevention.
|
650 |
|
0 |
|a Substance abuse
|v Encyclopedias.
|
650 |
1 |
2 |
|a Substance-Related Disorders
|v Encyclopedias
|x English.
|
650 |
|
7 |
|a Substance abuse.
|2 fast
|0 http://id.worldcat.org/fast/fst01136767
|
655 |
|
7 |
|a Encyclopedias.
|2 fast
|0 http://id.worldcat.org/fast/fst01423798
|
700 |
1 |
|
|a Fisher, Gary L.
|0 http://id.loc.gov/authorities/names/n89654790
|1 http://viaf.org/viaf/117249530
|
700 |
1 |
|
|a Roget, Nancy A.
|0 http://id.loc.gov/authorities/names/n2008182451
|1 http://viaf.org/viaf/271774188
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 243e6e7e-ba3c-55b8-977b-8269272d1532
|s 7bf3689c-a3f6-54f7-8eb1-8103c201efd6
|
928 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|l SSAd
|c SWL-SWL
|i 658722
|
928 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|l JRL
|c JRL-RR
|i 651478
|
928 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|l JCL
|c JCL-SciRR
|i 672195
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.1
|l SSAd
|c SWL-SWLRef
|b 088714811
|i 8532414
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.2
|l SSAd
|c SWL-SWLRef
|b 088714829
|i 8532415
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.2
|l JRL
|c JRL-RR
|b 80403276
|i 8532413
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.1
|l JRL
|c JRL-RR
|b 80403334
|i 8532412
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.1
|l JCL
|c JCL-SciRR
|e CRERAR
|b 089492658
|i 8532416
|
927 |
|
|
|t Library of Congress classification
|a RC563.4 .E53 2009
|v v.2
|l JCL
|c JCL-SciRR
|e CRERAR
|b 089492640
|i 8532417
|